Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study

被引：1
|
作者：
Gomez-Almaguer, David [1 ]
Cantu-Rodriguez, Olga [1 ]
Gutierrez-Aguirre, Cesar Homero [1 ]
Jaime-Perez, Jose Carlos [1 ]
Tarin-Arzaga, Luz C. [1 ]
Cardenas, Monica Sanchez [2 ]
Lozano-Morales, Rosa Elena [1 ]
Duque, Guillermo Sotomayor [1 ]
Cardenas-Araujo, Daniela [1 ]
Gomez-de Leon, Andres [1 ]
Santana-Hernandez, Paola [1 ]
Colunga-Pedraza, Perla Rocio [1 ]
机构：
[1] Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Hematol, Monterrey, Mexico
[2] Hosp Univ Dr Jose Eleuterio Gonzalez, Internal Med, Monterrey, Mexico
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1369.1369
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1369
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Romiplostim, Low-Dose Rituximab and High-Dose Dexamethasone Combination in Newly Diagnosed Immune Thrombocytopenia: Another "Total Therapy" Pilot Study
    Colunga-Pedraza, Perla R. R.
    Bustillos Munoz, Monica
    De La Garza, Fernando
    Gomez-De Leon, Andres
    Ulises Coronado-Alejandro, Edgar
    Gomez Gomez, Eliezer Tomas
    Varela-Constantino, Ana
    De la rosa-Flores, Gerardo A.
    Cantu Rodriguez, Olga Graciela
    Homero Gutierrez-Aguirre, Cesar
    Tarin Arzaga, Luz del Carmen
    Gomez-Almaguer, David
    BLOOD, 2021, 138
  • [2] Romiplostim, low-dose rituximab and high-dose dexamethasone for newly diagnosed immune thrombocytopenia: A pilot study
    Colunga-Pedraza, Perla R.
    De la Garza-Salazar, Fernando
    Vaquera-Alfaro, Hector A.
    Gomez-De Leon, Andres
    Bustillos-Munoz, Monica
    Tarin-Arzaga, Luz
    Cantu-Rodriguez, Olga
    Gutierrez-Aguirre, Cesar Homero
    Gomez-Almaguer, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [3] Low-dose rituximab, eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults
    Gomez-Almaguer, D.
    Colunga-Pedraza, P. R.
    Cantu-Rodriguez, O. G.
    Jaime-Perez, J. C.
    Gutierrez-Aguirre, C. H.
    Tarin-Arzaga, L.
    Sanchez-Cardenas, M.
    Sotomayor-Duque, G.
    Lozano-Morales, R. E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 50 - 51
  • [4] Low-dose rituximab plus high-dose dexamethasone in newly diagnosed immune thrombocytopenia
    Coronado-Alejandro, Edgar Ulises
    Martinez-Hernandez, Juan Pablo
    Gomez-De Leon, Andres
    Colunga-Pedraza, Perla Rocio
    Jaime-Perez, Jose Carlos
    Cantu-Rodriguez, Olga Graciela
    Gutierrez-Aguirre, Cesar Homero
    Gomez-Almaguer, David
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (06) : 778 - 779
  • [5] Eltrombopag, low-dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia
    Gomez-Almaguer, David
    Colunga-Pedraza, Perla R.
    Gomez-De Leon, Andres
    Gutierrez-Aguirre, Cesar H.
    Cantu-Rodriguez, Olga G.
    Jaime-Perez, Jose C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (02) : 288 - 290
  • [6] Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults
    Gomez-Almaguer, David
    Herrera-Rojas, Miguel A.
    Jaime-Perez, Jose C.
    Gomez-De Leon, Andres
    Cantu-Rodriguez, Olga G.
    Gutierrez-Aguirre, Cesar H.
    Tarin-Arzaga, Luz
    Hernandez-Reyes, Jesus
    Ruiz-Arguelles, Guillermo J.
    BLOOD, 2014, 123 (25) : 3906 - 3908
  • [7] Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia
    Hu Zhou
    Liu Liu
    Xinhui Shu
    Xiaoran Wang
    Yongping Song
    Indian Journal of Hematology and Blood Transfusion, 2019, 35 : 507 - 512
  • [8] Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia
    Zhou, Hu
    Liu, Liu
    Shu, Xinhui
    Wang, Xiaoran
    Song, Yongping
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2019, 35 (03) : 507 - 512
  • [9] Low-Dose Rituximab and High-Dose Dexamethasone As Front-Line Therapy in Adult Patients with Primary Immune Thrombocytopenia
    Gomez-Almaguer, David
    Tarin-Arzaga, Luz C.
    Moreno-Jaime, Brizio
    Jaime-Perez, Jose C.
    Ceballos-Lopez, Adrian A.
    Ruiz-Argueelles, Guillermo J.
    Ruiz-Delgado, Guillermo J.
    Cantu-Rodriguez, Olga
    Gutierrez-Aguirre, Cesar H.
    BLOOD, 2012, 120 (21)
  • [10] High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia
    Gomez-Almaguer, David
    Tarin-Arzaga, Luz
    Moreno-Jaime, Brizio
    Carlos Jaime-Perez, Jose
    Alejandro Ceballos-Lopez, Adrian
    Ruiz-Argueelles, Guillermo J.
    Ruiz-Delgado, Guillermo J.
    Graciela Cantu-Rodriguez, Olga
    Homero Gutierrez-Aguirre, Cesar
    Sanchez-Cardenas, Monica
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (06) : 494 - 500
12345